Cleared Traditional

Full Automatic(NIBP) Blood Pressure Monitor (K180240) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2018
Decision
261d
Days
Class 2
Risk

K180240 is an FDA 510(k) clearance for the Full Automatic(NIBP) Blood Pressure Monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Health & Life Co., Ltd. (Zhonghe District, New Taipei City, TW). The FDA issued a Cleared decision on October 17, 2018 after a review of 261 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Health & Life Co., Ltd. devices

Submission Details

510(k) Number K180240 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 29, 2018
Decision Date October 17, 2018
Days to Decision 261 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
136d slower than avg
Panel avg: 125d · This submission: 261d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 269
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K180240.
Wrist Blood Pressure Monitor Model BP4350
K182166 · Omron Healthcare, Inc. · Nov 2018
Finapres Nova Noninvasive Hemodynamic Monitor
K173916 · Finapres Medical Systems B.V. · Nov 2018
Wrist Blood Pressure Monitor Model BP6100
K182127 · Omron Healthcare, Inc. · Nov 2018
Bluetooth blood pressure monitor
K182018 · Shenzhen Kingyield Technology Co., Ltd. · Oct 2018
Arm type Blood Pressure Monitor, Digital Blood Pressure Monitor-Automatic Upper Arm Style
K181104 · Shenzhen Combei Technology Co., Ltd. · Aug 2018
Non-invasive blood pressure measurement systems
K173024 · Joytech Healthcare Co. , Ltd. · Aug 2018